Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.38 |
| ▸ | TSPO | P30536 | 1/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10165712 | 0.98 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL10165744 | 0.98 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL10165730 | 0.96 | LIMK1 (0.40) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL13830037 | 0.95 | KDM4E (0.38) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL780694 | 0.94 | KDM4E (0.37) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL10165720 | 0.94 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL781299 | 0.93 | KDM4E (0.36) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL780682 | 0.93 | KDM4E (0.36) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL17166669 | 0.93 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMLIMK1TSPO | |
| SCHEMBL780827 | 0.92 | KDM4E (0.35) | L3MBTL1KDM4EATMLIMK1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | NUTF2, BRI3BP, CLINT1 | L3MBTL1 1016/4885KDM4E 2172/4885ATM 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.